Market Overview
Korean equities were mixed in the session captured at 2026-07-13T00:30:28.918Z. The KOSPI stood at 7,447.12, down 0.39%, while the KOSDAQ advanced 3.04% to 862.85, showing stronger risk appetite in growth and momentum names.
The day was defined by sharp moves in newly listed and high-volume stocks, while large-cap semiconductor bellwethers remained central to market attention. The split between a weaker KOSPI and a stronger KOSDAQ suggested that trading interest was concentrated in selected themes rather than broad index strength.
Key Themes
- IPO and listing momentum: REMEDI was the clearest example, surging 40.82% after its KOSDAQ debut drew heavy trading activity. Reference articles from Newspim, Edaily, and Hankyung all focused on its listing and early-session strength.
- Robotics and shareholder actions: ANROBOTICS jumped 25.07%, with attention supported by reports on after-hours strength and its planned cancellation of treasury shares worth 4.2 billion won.
- High-volume small-cap rallies: Lightron Fiber-Optic Devices rose 20.86%, extending recent attention around its share-price rebound and sharp intraday gains reported by local media.
- Energy infrastructure: SK Eternix gained 18.79%, standing out in the energy infrastructure theme as articles highlighted volatility, rapid early-week gains, and expectations around power business expansion.
- Biotech downside risk: HLB fell 22.27% after reports said its U.S. approval process for a liver cancer drug had again faced a setback, making it the key negative stock-specific story of the day.
- AI and semiconductor attention: Samsung Electronics rose 0.53% and remained a high-volume market bellwether, with articles focusing on semiconductor capacity plans and service-material cost increases.
Stocks in Focus
REMEDI (387690)
REMEDI was the standout momentum name of the session, rising 40.82% on heavy trading activity. The move followed its KOSDAQ listing, which was covered in Newspim's "[주간IPO] 레메디, 코스닥 상장" (https://www.newspim.com/news/view/20260710001352) and Edaily's "'저선량·초소형 X-ray 솔루션' 레메디, 코스닥 데뷔[오늘 상장]" (https://www.edaily.co.kr/news/newspath.asp?newsid=02082806645514192). Hankyung also reported that the stock was "급등" in early trading on its first day (https://www.hankyung.com/article/2026071308796).
The supplied articles frame REMEDI as a newly listed medical technology company associated with low-dose and ultra-compact X-ray solutions. Based on the provided data, the stock's surge reflected listing-day demand and concentrated momentum rather than a broad market move.
ANROBOTICS (138360)
ANROBOTICS rose 25.07%, making it one of the strongest high-volume movers of the day. NewsPrime had previously included ANROBOTICS among after-hours limit-up names in "[시간외Y] 한진칼우, 앤로보틱스 '상한가'" (http://www.newsprime.co.kr/news/article.html?no=739935), while Edaily reported that the company planned to cancel treasury shares worth 4.2 billion won (https://www.edaily.co.kr/news/newspath.asp?newsid=04664166645513208).
The move appears to have combined momentum trading with attention to corporate action. The supplied disclosures and headlines were enough to keep the stock in focus, especially given the size of the daily gain.
Lightron Fiber-Optic Devices (069540)
Lightron Fiber-Optic Devices gained 20.86%, marking a notable volume-backed rally. TopStarNews reported that the stock had recently turned upward over the past five trading sessions (https://www.topstarnews.net/news/articleView.html?idxno=16131296), while other supplied articles highlighted sharp gains, including a July 10 intraday move to 2,325 won, up 29.88% (https://www.joongangenews.com/news/articleView.html?idxno=532011).
The provided data supports a simple reading: the stock remained in a short-term momentum phase, with recent price strength and high trading interest keeping it prominent among KOSDAQ names.
SK Eternix (475150)
SK Eternix advanced 18.79%, standing out as a sharp mover in the energy infrastructure theme. CBCI reported a volatility interruption and rapid early-week price rise (https://www.cbci.co.kr/news/articleView.html?idxno=588654), while Pinpoint News linked market attention to expansion in the power business (https://www.pinpointnews.co.kr/news/articleView.html?idxno=467825).
The move also came after reports of widened volatility around the 40,000 won range in the second week of July (https://www.joongangenews.com/news/articleView.html?idxno=532194). Based on the supplied information, SK Eternix was one of the session's most visible energy infrastructure names.
HLB (028300)
HLB was the key downside mover, falling 22.27% on heavy volume. The decline followed a set of supplied articles focused on the company's U.S. approval process for a liver cancer drug. News1 reported that HLB had secured FDA inspection comments and started a reapproval procedure (https://www.news1.kr/bio/pharmaceutical-bio/6225711). EToday described another failure to secure FDA approval for rivoceranib (https://www.etoday.co.kr/news/view/2602425), while Newsis reported that U.S. approval had again fallen through and that a fourth application would be pursued (https://www.newsis.com/view/NISX20260710_0003704342).
The sharp drop reflected the market's reaction to regulatory uncertainty in a major drug-development story. No additional clinical or financial figures were provided, so the focus remains on the reported approval setback and the scale of the daily share-price decline.
Samsung Electronics (005930)
Samsung Electronics rose 0.53%, a modest move compared with the day's smaller-cap momentum names, but it remained a market-leading high-volume bellwether. The supplied articles kept attention on both operational costs and semiconductor capacity. Yonhap reported higher service-material costs tied to broader chip-related inflation pressure (https://www.yna.co.kr/view/AKR20260712045900003?input=1195m). Donga and News1 reported that Samsung Electronics was moving up the operating target for its Yongin semiconductor fab to 2029 (https://www.donga.com/news/Economy/article/all/20260712/134281651/1; https://www.news1.kr/industry/general-industry/6225203).
Within the market snapshot, Samsung's small gain stood as a stabilizing large-cap semiconductor signal, even as the more dramatic moves came from KOSDAQ momentum stocks.
Market Headlines
- KOSPI opened lower and traded mixed around the 7,400 level, while KOSDAQ started higher, according to MBC.
- Seoul Economic Daily highlighted the paradox of a strong KOSPI rally alongside a PER level described as lower than during the financial crisis, with AI-related enthusiasm in focus.
- Semiconductor names remained central to market attention, with supplied headlines pointing to Samsung Electronics, SK Hynix, global chip stocks, and semiconductor-linked ETF products.
- Mirae Asset Life expanded its variable insurance fund lineup with Korea, U.S., and China semiconductor ETFs.
- KB Securities said its "Today's Kok" service surpassed 10 million cumulative views this year.
- Joosung Engineering was also flagged in supplied market news for a volatility interruption and a jump in early-week trading.
Closing Note
The session showed a clear split: the KOSPI slipped, but the KOSDAQ rallied strongly as traders concentrated on IPO, robotics, fiber-optic, energy infrastructure, and selected semiconductor-related stories. The most important takeaway was not broad market strength, but a sharp rotation into specific high-volume movers while regulatory risk weighed heavily on HLB.